WinstonWınston
Blackstone Mortgage Trust logo

Blackstone Mortgage Trust

BXMT
48
REIT - Mortgage · Real Estate
Price
$14.15
+0.31 (+2.24%)
Market Cap
$2.38B
Exchange
New York Stock Exchange
Winston Score
48
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 9, 2026 · filings through Jun 30, 2026

Share count rising — dilution

+12.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 151.5M (2021) → 171.0M (2025)

Blackstone Mortgage Trust is a real estate finance company that lends money to owners of large commercial properties like office buildings, hotels, and apartment complexes. Instead of owning buildings itself, it acts as the bank — providing loans to real estate investors who need financing. It is managed by Blackstone, one of the largest alternative asset managers in the world, which gives it access to large, institutional-quality borrowers.

The company makes money by collecting interest on the loans it originates, primarily floating-rate senior mortgages secured by properties across the United States, Europe, and Australia. It is structured as a real estate investment trust (REIT), meaning it must pay out most of its income as dividends to shareholders. Its main competitive advantage is its relationship with Blackstone's broader real estate network, but its biggest risk is credit quality — rising vacancies in commercial real estate, especially offices, have increased the chance that some borrowers may struggle to repay their loans.

Winston Score History

Politician Trades

4 trades / 12mo

1 Congressional buy and 3 sells on BXMT in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades
Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
69.5%
Premium pricing power — 69.5% gross margin
Operating Margin
36.7%
Excellent — 36.7% operating margin
ROCE
0.7%
Weak — 0.7% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-3.7%
Shrinking sales (-3.7% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
765%
Turns 765% of profit into real cash
FCF Margin
7.8%
Modest free cash flow (7.8%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
4.85
Heavy debt load (4.85)
Interest Cover
0.82x
Dangerous — barely covers interest (0.8x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
176.9x
Expensive — P/E 176.9

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+164.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (176.9 → 12.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
12.93%
Healthy income — 12.93% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial